Special focus on
- Genitourinary Cancers
- Internal medicine, University of Chicago, 1997
- Hematology/oncology, University of Chicago, 2000
- American Board of Internal Medicine (medical oncology), 2000
Dr. Ryan specializes in the treatment of sarcomas (rare bone and soft tissue tumors) and genitourinary cancers (kidney, bladder, prostate and testicle cancers). He strives to offer the latest treatments to his patients through clinical trials. He is inspired by his many patients who received breakthrough treatments in clinical trials before those treatments were widely available.
Dr. Ryan enjoys the Oregon outdoors, fly fishing for steelhead and cycling when he is given the chance. Most of all, he enjoys spending time with his wife and two small children.Read more
Memberships and associations
- American Society of Clinical Oncology
The following clinical trials are currently accepting new participants:
- A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin with Dacarbazine in Subjects with Soft Tissue Sarcoma
- A Randomized, Double-Blind Phase II, Study of Gemcitabine Alone or in Combination with Pazopanib for Refractory Soft Tissue Sarcoma
- A Multicenter, Open-Label Single-Arm Study of Yondelis® (trabectedin) for Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma Excluding Leiomyosarcoma and Liposarcoma Who Have Relapsed or Are Refractory to Standard of Care Treatment Protocol Number: ET743-SAR-3002 ¿ Phase IIIA Multicenter
- A Randomized Phase II Study of Afinitor (RAD001) vs. Sutent (Sunitinib) in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma (ASPEN)
- A Randomized Phase 3, Multicenter, Open-Label Study Comparing TH-302 in Combination with Doxorubicin vs. Doxorubicin Alone in Subjects with Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma
4.9 out of 5 (403 Ratings, 30 Comments)
The patient ratings score is an average of all responses to the question "How likely would you be to recommend this provider to your family and friends (on a scale of 0 to 10)" on our nationally-recognized NRC patient surveys.
- Jul 17, 2018
OHSU is a serious and effective provider with this user. Thanks
- Jul 11, 2018
Yes, I liked the doctor. I like him very much and I asked him questions and he answered them right back. That's what I like about him. Thank you.
- Jul 10, 2018
Dr Chris Ryan is compassionate, knowledgeable, a good listener and sincerely cares about his patients.
- Jul 10, 2018
It was great, easy to find where I was going and the staff were all very kind and helpful.
- May 24, 2018
I have utmost trust and confidence in Dr. Ryan. We have a very good rapport and ease of communication.
- Apr 29, 2018
We never felt rushed when talking to Dr Ryan.. He always made time for us, including 1 time where we were still there after clinic hours. Dr Ryan and his staff never made us feel that we need to hurry up..
- Aug 23, 2017
Dr. Ryan is trustworthy, inspires confidence, is knowledgeable in his field of expertise, and is reasonably personable.
- Aug 08, 2017
Dr Ryan is fantastic. He's well informed, caring and a very nice person.
- Aug 01, 2017
positive experience except the wait; was impressed that Dr Ryan called himself the next day with CT results, not an assistant
- Aug 01, 2017
Great MD and shows his caring and reassurance r/t my diagnosis. He's a great guy!